Trials / Completed
CompletedNCT01676571
Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women
A Single-centre, Open-label, Single-dose Interventional Study Investigating the Pharmacokinetic Properties of Lu AA21004 in Healthy Young Chinese Men and Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The rationale for this pharmacokinetic (PK) study is to determine the PK parameters for Lu AA21004 (Vortioxetine) in the Chinese population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lu AA21004 | 10 mg immediate-release (IR), one single dose, orally |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2012-11-01
- First posted
- 2012-08-31
- Last updated
- 2013-01-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01676571. Inclusion in this directory is not an endorsement.